Incidence, risk factors, and prognosis of inhospital heart failure after percutaneous coronary intervention: Insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

PrintPrintE-mailE-mail
Authors: 
Rabeea Aboufakher, MD
Authors: 
Arthur Riba, MD
Authors: 
Sandeep M. Jani, MPH
Authors: 
Raj Goswami, MD
Authors: 
Steven Schwartz, PhD
Authors: 
Sandra Lins, RN
Authors: 
Julius Gardin, MD
Authors: 
Dean E. Smith, MS, PhD
Authors: 
Eva Kline-Rogers, RN, MS
Authors: 
David Share, MD, MPH
Authors: 
Mauro Moscucci, MD
Hosting Publication: 
The American Heart Journal
Volume: 
September 2005

Heart failure (HF) has been shown to be an independent predictor of poor outcomes in patients undergoing percutaneous coronary intervention (PCI). Patients undergoing PCI with a history of HF are also at increased risk of major complications such as Q-wave myocardial infarction, stroke, or vascular complications. Despite evidence demonstrating that patients with HF are more likely to have poor outcomes, clinical predictors of the development of new-onset or inhospital HF remain ill defined. In addition, no study has investigated the independent prognostic implication of the development of new-onset or inhospital HF after PCI.